Transbound Emerg Dis 64(5):13461349 Kennedy EM, Denslow A, Hewett J, Kong L, De Almeida A, Bryant JD, Lee JS, Jacques J, Feau S, Hayes M et al (2022) Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer
Lowest effective dose tailored to you Fewer side effects minimal nausea, fatigue Better protein intake & muscle preservation Dose adjusted based on labs & response Hormone & root-cause investigation Built-in exit strategy from medication Sustainable, long-term results Fixed escalation regardless of response More nausea, vomiting, fatigue Significant muscle loss reported No labs, no individual monitoring Hormones & root causes never addressed No plan to come off medication Weight regain when medication stops How the 12-Week Program Works From your first consultation to your final follow-up, every step is designed to produce lasting results

Choose SRCP for: Active wound healing where penetration matters Scar remodeling and reduction Routines that include other active ingredients Oily or resilient skin types Maximum potency requirements Choose GHK-CU for: General anti-aging maintenance Sensitive or dry skin Simple routines without other actives Injectable protocols (GHK-CU has more research) Those who prefer naturally occurring compounds (GHK)-CU: The Stabilized Ratio Variant A less discussed but important variant is (GHK)-Cu, which uses a 2:1 ratio of GHK tripeptide to copper instead of the standard 1:1
The better option depends on your individual wellness goals, health history, and provider recommendations
Intended strictly for laboratory research, it supports controlled investigations into regenerative and immunomodulatory mechanisms and is not approved for human or veterinary use
According to research findings, PTC is less aggressive with HT, and there is less attack of lymph nodes and a smaller tumor